Low-dose trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT

Bone Marrow Transplantation

Volumn 46, Issue 12, 2011, Pages 1573-1575

  Muto, T ^a   Takeuchi, M ^a   Kawaguchi, T ^a   Tanaka, S ^a   Tsukamoto, S ^a   Sakai, S ^a   Takeda, Y ^a   Abe, D ^a   Ohwada, C ^a   Sakaida, E ^a   Shimizu, N ^a   Yokote, K ^b   Iseki, T ^a   Nakaseko, C ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; COTRIMOXAZOLE; DAPSONE; IMMUNOSUPPRESSIVE AGENT; PENTAMIDINE;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; CD4 LYMPHOCYTE COUNT; CHRONIC GRAFT VERSUS HOST DISEASE; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; KIDNEY DISEASE; LETTER; LEUKEMIA RELAPSE; LIVER DYSFUNCTION; LOW DRUG DOSE; MYELOABLATIVE CONDITIONING; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RASH; REDUCED INTENSITY CONDITIONING; RESPIRATORY FAILURE; RISK FACTOR; SURGICAL MORTALITY; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; DRUG COMBINATIONS; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; SULFADOXINE; TRANSPLANTATION, HOMOLOGOUS; TRIMETHOPRIM;

EID: 84856078461     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.335     Document Type: Letter

References (10)

1. Meyers JD, Pifer LL, Sale GE, Thomas ED. The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis 1979; 120: 1283-1287. (Pubitemid 10207914)
2. Wingard JR, Mellits ED, Sostrin MB, Chen DY, Burns WH, Santos GW et al. Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution. Medicine (Baltimore) 1988; 67: 175-186.
3. Tuan IZ, Dennison D, Weisdorf DJ. Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplant 1992; 10: 267-272.
4. Thomas Jr CF, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004; 350: 2487-2498.
5. Souza JP, Boeckh M, Gooley TA, Flowers ME, Crawford SW. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clin Infect Dis 1999; 29: 1467-1471. (Pubitemid 30022742)
6. Gea-Banacloche J, Masur H, Arns da Cunha C, Chiller T, Kirchhoff LV, Shaw P et al. Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Bone Marrow Transplant 2009; 44: 489-494.
7. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 2007; Issue 3: CD005590.
8. Vasconcelles MJ, Bernardo MV, King C, Weller EA, Antin JH. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol Blood Marrow Transplant 2000; 6: 35-43.
9. Center for International Blood, Marrow Transplant Research (CIBMTR); National Marrow Donor Program (NMDP); European Blood, Marrow Transplant Group (EBMT); American Society of Blood, Marrow Transplantation (ASBMT); Canadian Blood, Marrow Transplant Group (CBMTG); Infectious Disease Society of America (IDSA); Society for Healthcare Epidemiology of America (SHEA); Association of Medical Microbiology, Infectious Diseases Canada (AMMI); Centers for Disease Control Prevention (CDC). Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant 2009; 44: 453-558.
10. El-SadrWM, Luskin-Hawk R, Yurik TM, Walker J, Abrams D, John SL et al. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virusinfected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Clin Infect Dis 1999; 29: 775-783. (Pubitemid 30256366)